dexmethylphenidate has been researched along with dov 216303 in 1 studies
| Studies (dexmethylphenidate) | Trials (dexmethylphenidate) | Recent Studies (post-2010) (dexmethylphenidate) | Studies (dov 216303) | Trials (dov 216303) | Recent Studies (post-2010) (dov 216303) |
|---|---|---|---|---|---|
| 10 | 0 | 4 | 6 | 0 | 3 |
| Protein | Taxonomy | dexmethylphenidate (IC50) | dov 216303 (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.8 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 1.3 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 3.89 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 0.0498 | |
| Sodium-dependent dopamine transporter | Rattus norvegicus (Norway rat) | 0.0215 | |
| Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.1653 | |
| Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.0328 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 1.6 | |
| Sodium-dependent dopamine transporter | Homo sapiens (human) | 0.1363 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Subbaiah, MAM | 1 |
1 review(s) available for dexmethylphenidate and dov 216303
| Article | Year |
|---|---|
Triple Reuptake Inhibitors as Potential Therapeutics for Depression and Other Disorders: Design Paradigm and Developmental Challenges.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Drug Design; Humans; Selective Serotonin Reuptake Inhibitors | 2018 |